Latest Articles
Insights and limitations of endometrial cancer risk prediction models for clinical applicability: a systematic review - BMC Cancer
Insights and limitations of endometrial cancer risk prediction models for clinical applicability: a systematic review BMC Cancer
Published: Nov. 19, 2025, 10:29 a.m.
Diabetes Significantly Increases Fracture Risk in Women with Endometrial Cancer, Study Finds - Medical Dialogues
Diabetes Significantly Increases Fracture Risk in Women with Endometrial Cancer, Study Finds Medical Dialogues
Published: Nov. 19, 2025, 5:48 a.m.
Advanced Endometrial Cancer Pipeline 2025: FDA Updates, - openPR.com
Advanced Endometrial Cancer Pipeline 2025: FDA Updates, openPR.com
Published: Nov. 18, 2025, 6:59 p.m.
An assisted diagnostic and prognostic model for endometrial cancer using 36 serological markers and clinical variables from 562 patients - Nature
An assisted diagnostic and prognostic model for endometrial cancer using 36 serological markers and clinical variables from 562 patients Nature
Published: Nov. 18, 2025, 2:28 p.m.
The association between metabolic syndrome and incidence of endometrial cancer: a meta-analysis - Diabetology & Metabolic Syndrome
The association between metabolic syndrome and incidence of endometrial cancer: a meta-analysis Diabetology & Metabolic Syndrome
Published: Nov. 17, 2025, 6:01 p.m.
Patients with early Endometrial Cancer who don't undergo Hysterectomy have Higher Mortality: Study - Medical Dialogues
Patients with early Endometrial Cancer who don't undergo Hysterectomy have Higher Mortality: Study Medical Dialogues
Published: Nov. 16, 2025, 4:30 p.m.
Ane Gerda Zahl Eriksson: SENSOR-LIIFE - Advancing Exercise Research in Endometrial Cancer Survivor - Oncodaily
Ane Gerda Zahl Eriksson: SENSOR-LIIFE - Advancing Exercise Research in Endometrial Cancer Survivor Oncodaily
Published: Nov. 16, 2025, 9:57 a.m.
Endometrial Cancer Cure Rate: What Patients Need to Know in 2025 - Oncodaily
Endometrial Cancer Cure Rate: What Patients Need to Know in 2025 Oncodaily
Published: Nov. 16, 2025, 8:17 a.m.
FDA approves Promega’s OncoMate test to guide personalised treatment for endometrial cancer - Indian Pharma Post
FDA approves Promega’s OncoMate test to guide personalised treatment for endometrial cancer Indian Pharma Post
Published: Nov. 14, 2025, 3:26 p.m.
Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression - Cancer Cell International
Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression Cancer Cell International
Published: Nov. 14, 2025, 4:25 a.m.
Link copied to clipboard!